Barry Callebaut AG
XBER:BCLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Barry Callebaut AG
XBER:BCLN
|
CH |
|
Sunny Optical Technology Group Co Ltd
F:SXC
|
CN |
|
P
|
Proteome Sciences PLC
OTC:PMSNF
|
UK |
|
S
|
Scicom (Msc) Bhd
KLSE:SCICOM
|
MY |
|
Semler Scientific Inc
F:6FA
|
US |
|
R
|
Rockwell Automation Inc
LSE:0KXA
|
US |
|
A
|
Algonquin Power & Utilities Corp
F:751
|
CA |
Wall St Price Targets
BCLN Price Targets Summary
Barry Callebaut AG
According to Wall Street analysts, the average 1-year price target for BCLN is 1 975.76 EUR with a low forecast of 1 455.22 EUR and a high forecast of 3 397.63 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BCLN's stock price target?
Price Target
1 975.76
EUR
According to Wall Street analysts, the average 1-year price target for BCLN is 1 975.76 EUR with a low forecast of 1 455.22 EUR and a high forecast of 3 397.63 EUR.
What is the Revenue forecast for Barry Callebaut AG?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is -1%.
What is the Operating Income forecast for Barry Callebaut AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Barry Callebaut AG?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 21%.
